BridgeBio Pharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBIO and other ETFs, options, and stocks.

About BBIO

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development.

CEO

Neil Kumar

CEONeil Kumar

Employees

550

Employees550

Headquarters

Palo Alto, California

HeadquartersPalo Alto, California

Founded

2015

Founded2015

Employees

550

Employees550

BBIO Key Statistics

Market cap

6.73B

Market cap6.73B

Price-Earnings ratio

-14.76

Price-Earnings ratio-14.76

Dividend yield

—

Dividend yield—

Average volume

2.89M

Average volume2.89M

High today

$36.17

High today$36.17

Low today

$32.59

Low today$32.59

Open price

$33.73

Open price$33.73

Volume

7.64M

Volume7.64M

52 Week high

$41.04

52 Week high$41.04

52 Week low

$21.62

52 Week low$21.62

BBIO News

TipRanks 1d

BridgeBio Pharma Reports Strong Drug Uptake and Trial Progress

Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investme...

Analyst ratings

88%

of 17 ratings

Buy

88.2%

Hold

11.8%

Sell